Featured Research

from universities, journals, and other organizations

Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment

Date:
August 10, 2005
Source:
Johns Hopkins Medical Institutions
Summary:
Johns Hopkins researchers have, for what is believed to be the first time, used a magnetic resonance imaging (MRI) technique called diffusion-weighted MRI (DWI), a technique that images the movement, or diffusion, of water molecules in tissues, to successfully determine the effectiveness of high-intensity focused ultrasound for treating uterine fibroids. Uterine fibroids are noncancerous tumors that line the uterine wall and can cause intense pain and bleeding. The study appears in the July edition of Radiology.

Johns Hopkins researchers have, for what is believed to be the firsttime, used a magnetic resonance imaging (MRI) technique calleddiffusion-weighted MRI (DWI), a technique that images the movement, ordiffusion, of water molecules in tissues, to successfully determine theeffectiveness of high-intensity focused ultrasound for treating uterinefibroids. Uterine fibroids are noncancerous tumors that line theuterine wall and can cause intense pain and bleeding. The study appearsin the July edition of Radiology.

Ultrasound treatment works by directing focused ultrasound energythat heats the targeted tissue to induce cell damage or death withoutdamaging the surrounding tissue. Because it's noninvasive, thetreatment provides a desirable alternative to conventional surgery andwas undergoing clinical trials nationally and was recently given FDAapproval.

When fibroids or other tissues are damaged or destroyed by ultrasoundtreatment, water molecules are trapped within the tissue because thecellular pumps that control the movement of water into or out of cellsno longer function properly. By measuring the movement of this waterusing DWI, the researchers hoped to better gauge the impact oftreatment on the fibroids by using a quantitative biophysical parametercalled the apparent diffusion coefficient (ADC).

Currently, treatment success is determined using regular MRIwith a contrast agent (a dye injected into the patient to enhance theresulting image). However, the image produced during this proceduredoes not precisely show functional information on the degree of fibroiddestruction. Therefore, physicians also rely on questionnairesadministered to patients after their fibroid treatment, which often arevery subjective and unreliable.

In the study, 14 patients with uterine fibroids received ultrasoundtreatment and subsequent MR imaging using three different MRtechniques: conventional MRI, MRI with contrast material, and DWI MRI.Results showed significantly greater signal intensity on DWI ofultrasound treated fibroids than on the images of untreated fibroids ortreated fibroids obtained with the other MR methods. These results wereconfirmed in the 12 patients who took part in the six-month follow upstudy. Also observed were differences in the ADC. The DWI technique wasable to map the ADC in fibroids, showing lower ADC values in treatedfibroids than in surrounding tissue, a measure of restricted cellularwater flow due to the ultrasound treatment.

"While these results are preliminary and more research is needed, theystrongly suggest that the diffusion-weighted MR technique providesimages that show functional changes and the extent of fibroid damagefrom treatment. DWI may be useful for monitoring the effects ofultrasound treatment on uterine fibroids," says Michael Jacobs, Ph.D.,assistant professor of radiology and oncology at the Russell H. MorganDepartment of Radiology and Radiological Science at Johns Hopkins. "Theresults also suggest that this imaging technique may be useful formonitoring other focused ultrasound treatments for lesions in theprostate, and breast, when available." The other co-authors of thestudy were Hyun "Kevin" Kim, M.D. and Edward Herskovits, M.D., Ph.D.This study was supported in part by grants from the National Institutesof Health.



Story Source:

The above story is based on materials provided by Johns Hopkins Medical Institutions. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins Medical Institutions. "Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment." ScienceDaily. ScienceDaily, 10 August 2005. <www.sciencedaily.com/releases/2005/08/050809065346.htm>.
Johns Hopkins Medical Institutions. (2005, August 10). Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment. ScienceDaily. Retrieved September 3, 2014 from www.sciencedaily.com/releases/2005/08/050809065346.htm
Johns Hopkins Medical Institutions. "Hopkins Researchers Use Diffusion MRI Technique To Monitor Ultrasound Uterine Fibroid Treatment." ScienceDaily. www.sciencedaily.com/releases/2005/08/050809065346.htm (accessed September 3, 2014).

Share This



More Health & Medicine News

Wednesday, September 3, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Snack Attack: Study Says Action Movies Make You Snack More

Snack Attack: Study Says Action Movies Make You Snack More

Newsy (Sep. 2, 2014) You're more likely to gain weight while watching action flicks than you are watching other types of programming, says a new study published in JAMA. Video provided by Newsy
Powered by NewsLook.com
U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

U.N. Says Ebola Travel Restrictions Will Cause Food Shortage

Newsy (Sep. 2, 2014) The U.N. says the problem is two-fold — quarantine zones and travel restrictions are limiting the movement of both people and food. Video provided by Newsy
Powered by NewsLook.com
Doctors Fear They're Losing Battle Against Ebola

Doctors Fear They're Losing Battle Against Ebola

AP (Sep. 2, 2014) As a third American missionary is confirmed to have contracted Ebola in Liberia, doctors on the ground in West Africa fear they're losing the battle against the outbreak. (Sept. 2) Video provided by AP
Powered by NewsLook.com
Tech Giants Bet on 3D Headsets for Gaming, Healthcare

Tech Giants Bet on 3D Headsets for Gaming, Healthcare

AFP (Sep. 2, 2014) When Facebook acquired the virtual reality hardware developer Oculus VR in March for $2 billion, CEO Mark Zuckerberg hailed the firm's technology as "a new communication platform." Duration: 02:24 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins